Last reviewed · How we verify
NCT06973408: SWITCH
The SWITCH Dietary and Behavioural Intervention Study
NA trial testing Behavioral Treatment in Dietary Behaviour in 300 participants. Currently enrolling.
30 November 2026
Quick facts
| Lead sponsor | Chalmers University of Technology |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 300 |
| Start date | 3 March 2025 |
| Primary completion | 30 November 2026 |
| Estimated completion | 30 November 2026 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Behavioral Treatment — full drug profile →
- Food support
- Dietary Advice
Conditions studied
- Dietary Behaviour — all drugs for Dietary Behaviour →
- Dietary Intakes — all drugs for Dietary Intakes →
- Dietary Intervention — all drugs for Dietary Intervention →
- Metabolic Diseases — all drugs for Metabolic Diseases →
Sponsor
Chalmers University of Technology
Who can join
Adults 18 to 70, any sex, with Dietary Behaviour or Dietary Intakes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall objective of this study is to evaluate the effectiveness of an optimized lifestyle intervention based on dietary advice, behavioral support, and provision of key foods compared to dietary advice with behavioral support or dietary advice alone. The intervention aims to improve nutritional status, metabolic risk factors, and planetary sustainability. A total of 300 participants (150 men and 150 women) who meet all inclusion criteria and none of the exclusion criteria will be recruited. The study will be conducted at the Centre for Lifestyle Intervention at Östra Hospital in Gothenburg, led by researchers from Chalmers University of Technology, University of Gothenburg, and Sahlgrenska University Hospital. Participants will be recruited from two different socioeconomic areas in Gothenburg to examine how dietary interventions function in diverse population groups. The study follows a twelve-week randomized, controlled, parallel intervention design. Participants will be randomized into three groups, each with 100 individuals: Optimized lifestyle intervention group - receiving dietary advice, behavioral support, and provision of key foods. Behavioral support intervention group - receiving dietary advice and behavioral support. Control group - receiving dietary advice according to the SWITCH diet. The SWITCH diet, developed within the EU project SWITCH, is designed to align with European dietary guidelines and promote sustainable and healthy eating habits. It emphasizes whole grains, vegetables, fruits, legumes, and sustainable seafood while limiting processed foods, added sugars, and salt. Throughout the study, participants will undergo clinical assessments at baseline, midpoint (week 7), and endpoint (week 13). Key measurements include anthropometric data, blood pressure, blood glucose, blood lipids, and inflammatory markers. Dietary intake and sustainability aspects of food consumption will also be evaluated. Participants in the intervention groups will receive personalized coaching and access to practical resources, such as meal plans, recipes, and visual educational materials. The primary outcome of the study is the difference in cardiometabolic risk factors (e.g., blood lipids, blood pressure, glucose, insulin resistance markers) between the intervention groups. Secondary outcomes include changes in dietary intake, nutritional status markers, inflammatory markers, and sustainability measures (e.g., CO₂ emissions, land use, biodiversity impact). Additionally, exploratory analyses will investigate associations between diet, lifestyle changes, gut microbiota, and metabolic responses. This study aims to generate valuable insights into the effectiveness of different dietary intervention strategies in real-life Nordic conditions. The results will contribute to the development of evidence-based recommendations for sustainable and health-promoting dietary patterns.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06973408
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Behavioral Treatment
Trials testing the same drug.
- NCT07390786 — Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot · NA · recruiting
- NCT07032311 — Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk · NA · not yet recruiting
- NCT07018830 — Multicomponent Program for Addressing Cognition in Rural Communities · NA · completed
- NCT06467916 — The Development of PATH, a Program to Support NICU Parent Mental Health Through the Transition From Hospital to Home · NA · recruiting
- NCT07137117 — The Effect of Tele-Counseling Service on Nutrition, Exercise Attitude, and Medication Adherence After Bariatric Surgery · NA · recruiting
Other recruiting trials for Dietary Behaviour
Currently open trials in the same condition.
- NCT07417254 — Novel Personalised Nutrition Intervention With Tailored Behavioural Support · NA · recruiting
- NCT05932329 — Reducing Free Sugar Intakes: A Role for Sweet Taste II · NA · active not recruiting
- NCT05684757 — Reducing Free Sugar Intakes: A Role for Sweet Taste · NA · active not recruiting
Other Chalmers University of Technology trials
Trials by the same sponsor.
- NCT06897241 — Personalized Metabolic Responses to Rapid, Slow and Resistant Starch · NA · recruiting
- NCT06842433 — The NUTRIOME Study - a Data-driven Precision Nutrition Intervention · NA · recruiting
- NCT06587958 — Fermented Plant-based Portfolio Diet 4 Metabolic Health · NA · completed
- NCT06992921 — Towards Personalized Nutrition With SCAPIS2-HOME · NA · completed
- NCT05757154 — Coffee for Optimal Metabolite Profile · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06973408 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chalmers University of Technology
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06973408.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing